Advanced Cervical Cancer Survival Improvement with Bevacizumab

被引:0
|
作者
Klaiber-Hakimi, M. [1 ]
机构
[1] Univ Leipzig, Univ Krebszentrum Leipzig UCCL, D-04103 Leipzig, Germany
来源
ONKOLOGE | 2015年 / 21卷 / 01期
关键词
D O I
10.1007/s00761-014-2842-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:67 / 68
页数:2
相关论文
共 50 条
  • [1] Advanced Cervical Cancer: Bevacizumab extends Survival
    不详
    GYNAKOLOGE, 2018, 51 (08): : 599 - 599
  • [2] Bevacizumab extends survival in advanced cervical cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (07) : 370 - 370
  • [3] Improved Survival with Bevacizumab in Advanced Cervical Cancer
    Tewari, Krishnansu S.
    Sill, Michael W.
    Long, Harry J., III
    Penson, Richard T.
    Huang, Helen
    Ramondetta, Lois M.
    Landrum, Lisa M.
    Oaknin, Ana
    Reid, Thomas J.
    Leitao, Mario M.
    Michael, Helen E.
    Monk, Bradley J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08): : 734 - 743
  • [4] Improved Survival With Bevacizumab in Advanced Cervical Cancer
    Tewari, Krishnansu S.
    Sill, Michael W.
    Long, Harry J., III
    Penson, Richard T.
    Huang, Helen
    Ramondetta, Lois M.
    Landrum, Lisa M.
    Oaknin, Ana
    Reid, Thomas J.
    Leitao, Mario M.
    Michael, Helen E.
    Monk, Bradley J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (06) : 331 - 332
  • [5] Bevacizumab reported to increase overall survival in advanced cervical cancer
    Lake, Francesca
    FUTURE ONCOLOGY, 2014, 10 (05) : 787 - 787
  • [6] Bevacizumab in advanced cervical cancer
    Vlachostergios, P. J.
    Papandreou, C. N.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (10): : 935 - 935
  • [7] Bevacizumab for advanced cervical cancer
    Sharma, Sharan
    LANCET ONCOLOGY, 2014, 15 (04): : E155 - E155
  • [8] Bevacizumab in advanced cervical cancer
    P. J. Vlachostergios
    C. N. Papandreou
    Clinical and Translational Oncology, 2014, 16 : 935 - 935
  • [9] Bevacizumab Extends Cervical Cancer Survival
    McNutt, Marcia
    Farrar, Jeremy
    Lane, David
    CANCER DISCOVERY, 2013, 3 (07) : 709 - 709
  • [10] Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    FUTURE ONCOLOGY, 2015, 11 (06) : 909 - 922